- $550.60m
- $1.40bn
- $1.88bn
Evolent Health Inc reports results for the quarter ended in June - Earnings Summary
Brief: Evolent Health Q2 Revenue USD 469.136 Million Vs. IBES Estimate USD 460.7 Million
Evolent Health Inc expected to post earnings of 11 cents a share - Earnings Preview
Brief: Evolent Health Rebranding As Evolent
Brief: Evolent Health Inc - Sees 2023 Revenue In Range Of $1.935 Bln To $1.965 Bln
Evolent Health Inc reports results for the quarter ended in March - Earnings Summary
Brief: Evolent Health Announces First Quarter 2023 Results
Brief: Evolent Health posts Q1 revenue USD 427.69 million
Evolent Health Inc expected to post earnings of 20 cents a share - Earnings Preview
Evolent up on expanded pact with Centene for cancer specialty care
Brief: Evolent Health And Centene Agree To Expanded Partnership For Oncology Specialty Care For Medicare Advantage Members
U.S. RESEARCH ROUNDUP-Cinemark Holdings, Commercial Metals Co, Nvidia
Evolent Health Inc reports results for the quarter ended in December - Earnings Summary
Evolent Health Inc expected to post earnings of 16cents a share - Earnings Preview
Brief: Evolent Health Reaffirms Previously Issued Guidance For Year Ended Dec 31, 2022
NYSE ORDER IMBALANCE 101782.0 SHARES ON SELL SIDE
EVH up on acquiring Centene's specialty benefit management unit
U.S. RESEARCH ROUNDUP-Abbvie, Eli Lilly, Vroom
Brief: Evolent Health Announces Acquisition Of Specialty Asset NIA And Partnership With Centene